Structure via PubChem · Public domain (PubChem)
fencamfamin
Sign in to saveAlso known as Fencamfamine, Fencamfaminum, Fencanfamina
Fencamfamin (INN), also known as fencamfamine or by the brand names Glucoenergan and Reactivan, is a stimulant which was developed by Merck in the 1960s.
In the Vinony graph
Within Vinony's link graph, fencamfamin is referenced by 1,682 other articles, and connects out to Anatomical Therapeutic Chemical Classification System, histamine antagonist and 5-methoxy-N,N-diisopropyltryptamine.
Vinony files it under Drugboxes which contain changes to verified fields, Drugboxes which contain changes to watched fields and Norbornanes.
Its subject is documented across 10 Wikipedia language editions.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 443754176
- Drug.IUPAC_name
- N-Ethyl-3-phenyl-norbornan-2-amine
- Drug.image
- Fencamfamin Structure.svg
- Drug.image_class
- skin-invert-image
- Drug.pregnancy_category
- ?
- Drug.legal_BR
- B1
- Drug.legal_CA
- Schedule IV
- Drug.legal_US
- Schedule IV
- Drug.legal_DE
- Anlage II
- Drug.routes_of_administration
- Oral
- Drug.elimination_half life
- 16 hours
- Drug.CAS_number
- 1209-98-9
- Drug.ATC_prefix
- N06
- Drug.ATC_suffix
- BA06
- Drug.PubChem
- 14584
- Drug.DrugBank
- DB01463
via Wikipedia infobox
Chemical data
- Formula
- C15H21N
- Molecular weight
- 215.33 g/mol
- IUPAC name
- N-ethyl-3-phenylbicyclo[2.2.1]heptan-2-amine
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
- Indications
- attention deficit hyperactivity disorder
via ChEMBL · EBI
Research
69 papers- Fencamfamine.General pharmacology · 1990
- Amphetamine, mazindol, and fencamfamin in narcolepsy.British medical journal (Clinical research ed.) · 1985
- A CONTROLLED OUT-PATIENT TRIAL WITH FENCAMFAMIN.The British journal of psychiatry : the journal of mental science · 1964
- [Reserpine-parkinsonoid syndrome in the chimpanzee and its treatment with fencamfamin].Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie · 1968
- FENCAMFAMIN VERSUS PLACEBO IN DEPRESSED PATIENTS.The Journal of new drugs · 1964
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 215.1674
- Has use
- medication
Show 4 more facts
- chemical formula
- C₁₅H₂₁N
- canonical SMILES
- CCNC1C2CCC(C2)C1C3=CC=CC=C3
- subject has role
- stimulant
- Commons category
- Fencamfamine
Sources (2)
via Wikidata · CC0
~5 min read
Encyclopedic overview
8 sectionsContents
- Medical uses
- Adverse effects
- Contraindications
- Overdose
- Research
- Synthesis
- See also
- References
Fencamfamin (INN), also known as fencamfamine or by the brand names Glucoenergan and Reactivan, is a stimulant which was developed by Merck in the 1960s.
==Medical uses== Fencamfamin is still used, though rarely, for treating depressive day-time fatigue, lack of concentration and lethargy, particularly in individuals who have chronic medical conditions, as its favourable safety profile makes it the most suitable drug in some cases.
Excerpted from Wikipedia’s “fencamfamin” article, available under the CC BY-SA 4.0 licence.